Extrait

RATIONALE: Letrozole may prevent breast cancer in postmenopausal women with a BRCA1 or BRCA2 mutation. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works compared with a placebo in preventing breast cancer in postmenopausal women with a BRCA1 or BRCA2 mutation.

Critère d'inclusion

• BRCA1 Mutation Carrier ,BRCA2 Mutation Carrier ,Breast Cancer ,Hereditary Breast/Ovarian Cancer (brca1, brca2)

Liens

• ictrp
• nct